Learn More
In Crohn’s disease the optimal duration of azathioprine treatment is still controversial and for ulcerative colitis only limited data are available to support its efficacy. Charts of 1176 patients with IBD from 16 European centers were analyzed. Flare incidences and steroid dosages were assessed for the time before and during treatment and after(More)
In a survey comprising 1,176 patients with inflammatory bowel disease (IBD) we recently showed that azathioprine (AZA) beyond 4 years is beneficial in ulcerative colitis (UC) patients and in a subset of Crohn’s disease (CD) patients. Here, we show for the first time that azathioprine responsiveness depends on body mass index (BMI). The relationship is(More)
Im Verlaufe von 7 Jahren wurden 151 Patienten nach totaler Gastrektomie laufend nachuntersucht. Untersuchungen des Eisenstoffwechsels ergaben häufig Eisenmangelanämien, die peroral durch Zufuhr von Ferrogluconat behoben werden konnten. Auch bei vorhandener Anämie kam es nicht zu signifikanter Verminderung des Serumkupfers. Erst bei Auftreten(More)